C3.ai (AI: NYSE)

AI, a leading software-as-a-service provider and builder of artificial intelligence applications, currently holds a unique advantage in the market. With few serious competitors in the publicly-traded space, AI is well-positioned to capitalize on its current role. This can be attributed to the company’s CEO, Thomas Siebel, a seasoned veteran in the tech industry with a proven track record. Additionally, AI’s impressive customer base, primarily consisting of energy, industrial, and government clients, ensures a steady stream of high-paying customers. The company’s transition to a usage-based revenue model is expected to drive long-term growth. 

We continue to maintain our bullish outlook on the AI industry, but our optimism is only applicable if the stock remains above the $34.00-$35.00 mark. Our upside target is $62.00-$64.00, and we are confident that the industry has the potential to achieve these figures. As previously stated, in our previous post.

Caterpillar (CAT:NYSE)

CAT, the top supplier to mining and mineral extraction companies, has been taking significant measures to shift their business from a production-based model to a service-oriented one. This strategic change aims to reduce revenue and earnings cyclicality and increase their service revenue to $28 billion by 2026. With the evidence building that commodity prices will keep climbing, the demand for hard assets is increasing, which presents a significant opportunity for CAT. 

We believe that CAT has the potential to reach its upside target of $330.00-$340 because of its strong position in the market. As industry experts, we are bullish on CAT, particularly above $225.00-$227.00.

ATOM/USDT

Cosmos (ATOM) currently is trading around $8.27. It’s been on a major support for four weeks now, and price is oversold on higher timeframes. However, this could be good news for those who believe in ATOM’s potential, as it could lead to a potential move higher to test the upper range of the current support, at $9.50. 

If that level gets broken, price could target the next area of resistance at $10.00-$10.50. Of course, the opposite could also happen, and if the $8.27 support level is lost, then price could possibly go and test the next area of support at $8.00-$8.50. 

There is a possibility of further downside in the BTC Dominance, and once that happens, we see some further upside in the General Altcoin Market, as cash leaves BTC and flows into the Alts.

INJ/USDT

Injective Protocol (INJ) is currently trading in what could be considered a lower area of support, ranging from $7.60 to $8.20. 

However, this could be seen as a potential opportunity for savvy traders who keep a close eye on market trends. As INJ is currently oversold on certain higher time frames, there may be an indication that it could be gearing up for another move upward. Should this occur, it’s possible that INJ could be headed to test the next area of resistance at around $8.70 – $9.35, or potentially even the next major resistance point of $10.00 – $10.50. 

Of course, things could also go the other way and the area of support could be lost, which could see INJ dropping to the next major support area at around $6.50 – $7.00. There is hope, however, as many in the financial industry are predicting a drop in the BTC Dominance and an uptick in the Altcoin Market. With this in mind, prudent investors can stay ahead of the curve and be ready to make smart moves.